Header Image
3. Fatty acids, probiotics and more for ADHD

Sitemap

3. Fatty acids, probiotics and more for ADHD

Lipid metabolism in ADHD shows altered levels of various fatty acids, with patients having different lipid and fatty acid profiles.1
MPH and ATX influence ADHD symptoms via lipid metabolism, among other things2, in different directions3.
One study found no changes in lipid metabolism in ADHD4

3. Fatty acids for ADHD

A deficiency of polyunsaturated fatty acids in the blood serum of children with ADHD persisted into adulthood.5 ADHD symptoms in adults correlated with elevated levels of saturated stearic acid and monounsaturated fatty acids.5

3.1. Polyunsaturated fatty acids

Lower levels of polyunsaturated fatty acids (PUFAs) correlated with ADHD 67
One review came to the recommendation of a combination of EPA, DHA and GLA in a ratio of 9:3:1 for ADHD.8 The lead author is involved in a company that sells unsaturated fatty acids.

Rats fed a high-fat diet enriched with omega-3 fatty acids during lactation, after the mother had been fed a high-fat diet enriched with omega-6 fatty acids during pregnancy, suffered microcephaly (small head circumference) with reduced GLUT3 concentrations in the brain9

3.1.1. Omega-3 fatty acids

Omega-3 PUFAs are not synthesized in the human organism and must be taken in with food. If the diet is unbalanced, they must be supplemented. Foods with a high omega-3 PUFA content are linseed oil, linseed, chia seeds, walnut oil, walnuts, rapeseed oil, tuna, herring, salmon and mackerel.
The need for omega-3 PUFA is particularly high during growth phases (first years of life and puberty).
Omega-3 PUFAs are important for the anatomical and functional brain development of the brain. They influence the maturation and function of neurons and the processes of neurogenesis, migration, synaptogenesis and neurotransmission. They are substrates for the synthesis of bioactive compounds and are involved in the control of acute and chronic inflammation and the regulation of immune cells.10

Omega-3 fatty acids are among others:

  • Eicosapentaenoic acid (EPA)
  • Docosahexaenoic acid (DHA)
    • A combination of the triple unsaturated fatty acids EPA and DHA in rats in stress tests11
      • Prevented or compensated dendritic atrophy in the hippocampus CA3 region
      • Restored GABA release in the hippocampus CA1 region
      • Improved spatial memory.
  • Roughanic acid
  • Alpha-linolenic acid
  • Stearidonic acid
  • Eicosatetraenoic acid
  • Heneicosapentaenoic acid
  • Docosapentaenoic acid
  • Tetracosapentaenoic acid
    (scoliodonic acid)
  • Tetracosahexaenoic acid
    (nisic acid)

The clinically relevant long-term fatty acid supply is determined using the erythrocyte membrane (from EDTA blood). The fatty acid analysis in plasma, on the other hand, only determines the daily intake12

3.1.1.1. Omega-3 fatty acids for ADHD

Omega 3 fatty acids correlate with ADHD symptoms

  • in serum (daily supply)
    • found a review of 2 meta-analyses:13
      • reduced omega-3 blood levels (k = 9, n = 586)
      • Improvement of ADHD symptoms by omega-3 administration (k = 16, n = 1,408) at low potency (SMD according to Hedges g = 0.26) on hyperactivity (teacher and parent ratings) and inattention (only parent, not teacher ratings)
    • decreased14, which correlated with increased ADHD symptoms1516
    • unchanged for ADHD17
    • Alpha-linolenic acid
      • reduced in plasma18
    • Docosahexaenoic acid (DHA)
      • reduced; without correlation to ADHD symptoms5
      • significantly reduced19
      • increased in plasma18
    • Eicosapentaenoic acid (EPA)
      • significantly reduced19
      • increased in plasma18
  • in erythrocyte membranes (long-term supply)
    • reduces14,
    • Docosahexaenoic acid reduces20
3.1.1.2. Administration of omega-3 fatty acids for ADHD

A review of 2 meta-analyses found a small ((SMD according to Hedges g = 0.26)) Improvement in ADHD symptoms through omega-3 administration (k = 16, n = 1,408) with regard to hyperactivity (teacher and parent ratings) and inattention (only parent, not teacher ratings).13
A meta-analysis of k = 7 studies on n = 926 subjects found a statistically non-significant slight improvement in ADHD symptoms with omega 3 alone.21
An administration of 635 mg eicosapentaenoic acid (EPA) and 195 mg docosahexaenoic acid (DHA) (unsaturated fatty acids) reduced serum CRP and IL-6 levels in children with ADHD and improved ADHD symptoms within 8 weeks in a double-blind placebo study.22

A combination of the triple unsaturated fatty acids EPA and DHA in rats in stress tests11

  • Prevented or compensated dendritic atrophy in the CA3 region of the hippocampus
  • Restored GABA release in the CA1 region of the hippocampus
  • Improved spatial memory.

A placebo-controlled double-blind study found improvements in attention in children with ADHD as well as in children not affected by omega-3 fatty acids.23
A study of healthy adolescents found a trend towards an improvement in sustained attention and ADHD symptoms in those participants who consumed nuts more consistently when consuming walnuts over 6 months.24 This could reflect the fact that young people who perceive a benefit (even unconsciously) from consuming nuts are more likely to continue doing so.

One RCT found no improvement in ADHD-RS intention score or inattention with omega-3/6 supplementation at either 6 or 12 months. There was a positive response of 46.3% in the omega-3/6 group and 45.6% in the placebo group. The study used two capsules per day, each containing 279 mg eicosapentaenoic acid [EPA], 87 mg docosahexaenoic acid [DHA], 30 mg gamma-linolenic acid [GLA].25

Conclusion: Supplementation of omega-3 fatty acids could have a supportive effect. The achievable Effect size of 0.26 is too low to detect an improvement in an individual. Below an Effect size of 0.5, an improvement is only statistically detectable in one group. Treatment of ADHD with omega-3 fatty acids alone is therefore hopeless.

3.1.2. Omega-6 fatty acids

Omega-6 fatty acids are among others:

  • Arachidonic acid (AA)
  • Linoleic acid (LA)
  • Gamma-linolenic acid (GLA)
  • Dihomo-gamma-linolenic acid (DHGLA)
  • Adrenic acid
3.1.2.1. Omega-6 fatty acids for ADHD
3.1.2.2. Administration of omega-6 fatty acids for ADHD

One RCT found no improvement in ADHD-RS intention score or inattention with omega-3/6 supplementation at either 6 or 12 months. There was a positive response of 46.3% in the omega-3/6 group and 45.6% in the placebo group. The study used two capsules per day, each containing 279 mg eicosapentaenoic acid [EPA], 87 mg docosahexaenoic acid [DHA], 30 mg gamma-linolenic acid [GLA].25

Conclusion: Supplementation of omega-6 fatty acids has no effect on ADHD. The administration of omega-6 fatty acids (with the exception of arachidonic acid) could tend to have a detrimental effect.

3.2. Monounsaturated fatty acids

A study of genetic analyses found no evidence of a causal link between unsaturated fatty acids and ADHD.26
One study found no change ADHD in serum.17
Two very small studies found increased monounsaturated fatty acids in ADHD:

  • Omega-7 fatty acids
    • Palmitoleic acid elevated in serum, without correlation to ADHD symptoms5
  • Omega-9 fatty acids
    • Nervonic acid (reduces ADHD found in erithrocyte membranes mapping the long-term supply)20
    • Oleic acid
      • increased in erithrocyte membranes, which reflect the long-term supply)20
      • increased without correlation to ADHD symptoms5
      • reduced in plasma18

3.3. Saturated fatty acids

A large study of 432 children found significantly higher serum levels of saturated fat in children with ADHD.27 This correlated with an increased intake of nutrient-poor foods such as foods high in sugar and fat and a lower intake of vegetables, fruit and protein-rich foods than healthy children. It remains to be seen whether the change in diet is a cause, a consequence or a vicious circle.
Another study also found increased levels of saturated fatty acids in the blood (daily supply) and eritrhrocyte membranes (long-term supply) 14,
One study found no change ADHD in serum.17

4. Low-density lipoprotein

In children with ADHD, one study found significantly increased blood levels of total cholesterol and low-density lipoprotein (LDL), while high-density lipoprotein (HDL) and triglyceride (TG) levels did not differ from those of people with ADHD.28 In contrast, another study found significantly lower blood levels of total cholesterol, high-density lipoprotein (HDL) and low-density lipoprotein (LDL) in boys with ADHD (regardless of subtype).29
In adults, a large cohort study found a slightly reduced low-density lipoprotein (LDL) level.30
A KIGGS study found no differences in serum lipid parameters between ADHD (n = 1,219) and controls (n = 9,741) for total cholesterol, LDL, HDL, or triglycerides, either at baseline or at 10-year follow-up, even when MPH use was taken into account.31

Treatment of bipolar adults with comorbid ADHD with lisdexamfetamine (Vyvanse) resulted in significant decreases in weight, body mass index, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, but not triglycerides or blood glucose levels.32

A study suggests a genetic alteration of the receptor for low-density lipoprotein in ADHD33
LDL cholesterol elevated in serum, without correlation to ADHD symptoms
The fact that lipoprotein metabolism is altered in ADHD was also the result of another small study.34

Among other things, methylphenidate reduces the low-density lipoprotein level.35

Further studies on fats and fatty acids in ADHD did not lead to a clear result.36

5. Treatment of the gut-brain axis in ADHD

5.1. Probiotics for ADHD

For background information on gut bacteria, gut-brain axis and their role in the development of ADHD, see Gut bacteria, gut-brain axis (gut-brain axis) In the article Age-independent physical stress as an environmental cause of ADHD in the chapter Development.

Various studies report positive effects of probiotics in children with ADHD.

  • L. rhamnosus GG
    • Administration during the first 6 months of life reduced risk of later ADHD37
    • Giving children improved ADHD symptoms in the parent rating, but not in the teacher rating38
  • Bacteroidetes bifidum Bf-688
    • Administration to children improved inattention, hyperactivity/impulsivity, increased weight3940
      • Firmicutes reduced
      • Ratio of Firmicutes to Bacteroidetes (F/B ratio) reduced
      • Proteobacteria increased
      • improved neuropsychological performance (with co-medication with MPH)
      • reduced N-glycan biosynthesis (with co-medication with MPH)
      • significant improvement in omission errors in the CPT (with co-medication with MPH)
      • significant improvement in hit response time in CPT and CATA (with co-medication with MPH)
  • B. subtilis, B. bifidum, B. breve, B. infantis, B. longum, L. acidophilus, L. delbrueckii, L. casei, L. plantarum L. lactis, L. salivarius, S. thermophiles
    • Administration in addition to MPH improved ADHD symptoms in children compared to placebo41
  • L. reuteri, L. acidophilus, L. fermentum, B. bifidum
    • Administration improved ADHD symptoms RS in children compared to placebo. In addition, serum high-sensitivity C-reactive protein (hs-CRP) decreased and total antioxidant plasma volume (TAC) increased compared to placebo. CDI and other metabolic characteristics unchanged.42
  • L. mesenteroides, L. paracasei, L. plantarum, B-glucan, inulin
    • ADHD symptoms in children and adults improved to the same extent in the treatment group and placebo group, ASD symptoms remained unchanged43
  • Lactobacillus plantarum PTCC 1896™ (A7), Bifidobacterium animalis subsp. lactis (BB-12®)
    • Significant decrease in ADHD total scores on the CPRS (Connor Parent Rating Scale) after 4 weeks of administration in addition to MPH compared to placebo in addition to MPH, but no longer after 8 weeks of intervention.44
  • L. helveticus, B. animalis ssp. lactis, Enterococcus faecium, B. longum, Bacillus subtilis
    • Improvements in hyperactivity and academic performance. Improvements in ADHD symptoms correlated with lower cortisol levels. Double-blind RCT study over 3 months compared to placebo that observed ADHD symptoms, academic performance, FCC, gastrointestinal symptoms and sleep quality in college students with ADHD.45

A meta-analysis found no improvement with probiotics in ADHD.46

5.2. Fecal transplantation for ADHD

To date, the studies needed to assess whether fecal transplants are a treatment option for ADHD are lacking.

One study found that mice whose guts were contaminated with gut bacteria from people with ADHD had structural changes in the brain (white matter, gray matter, hippocampus, internal capsule), decreased connectivity between motor and visual cortices right in the resting state, and higher anxiety than mice in which gut bacteria from people without ADHD were used.47
A single case study reported an improvement in ADHD symptoms in a young woman with gut bacteria replacement related to a recurrent Clostridioides difficile infection.48

6. Other substances for ADHD

6.1. Polyphenols

Polyphenols are aromatic compounds with two or more hydroxyl groups directly bound to an aromatic ring. Polyphenols are formed from phenylalanine, which in turn is formed from shikimic acid.

Natural polyphenols (of which there are said to be over 8,000) are often contained in plants as bioactive substances (colorants, flavorings, tannins), e.g.

  • Flavonoids (colorants)
    • Flavonoids appear to have a glutamate-antagonistic and GABA-agonistic effect.49
  • Anthocyanins (colorants)
  • Procyanidins
  • Benzoic acid derivatives, e.g.
    • Vanillic acid
    • Gallic acid
    • Protocatechuic acid
  • Cinnamic acid derivatives, e.g.
    • Caffeic acid
    • Coumaric acid
  • Style derivatives, e.g.
    • Resveratrol
      • Component of red wine

Certain polyphenols are said to be able to influence neurophysiological changes caused by early childhood stress:50 e.g:

  • Reduction of depressive symptoms through
    • Xanthohumol
    • Quercetin
    • Phlorotannins
  • Reduction of anxiety symptoms through
    • Quercetin
    • Phlorotannins
  • Elimination of the BDNF reduction by
    • Xanthohumol
  • No correction of the dopamine and serotonin level changes in the brain stem triggered by early stress
  • Reduction of the cortisol stress response to acute stress through
    • Xanthohumol

One study found a correlation of increased polyphenol intake with reduced risk of ADHD in preschool children.51

6.2. Phosphatidylserine

Phosphatidylserine is not a vitamin, but a phospholipid.

Source: Bieger.52


  1. Grzymala B, Þorsteinsson H, Halldórsdóttir DÞ, Sveinsdóttir HS, Sævarsdóttir BR, Norton WHJ, Parker MO, Rolfsson Ó, Karlsson KÆ. Metabolomic and lipidomic profiling reveals convergent pathways in attention deficit hyperactivity disorder therapeutics: Insights from established and emerging treatments (2025): J Pharmacol Exp Ther. 2025 Feb 21;392(4):103403. doi: 10.1016/j.jpet.2025.103403. PMID: 40081232.

  2. Zhao Y, Fu Z, Barnett EJ, Wang N, Zhang K, Gao X, Zheng X, Tian J, Zhang H, Ding X, Li S, Li S, Cao Q, Chang S, Wang Y, Faraone SV, Yang L (2025): Genome data based deep learning identified new genes predicting pharmacological treatment response of attention deficit hyperactivity disorder. Transl Psychiatry. 2025 Feb 7;15(1):46. doi: 10.1038/s41398-025-03250-5. PMID: 39920114; PMCID: PMC11806042.

  3. Suzuki S, Kimura R, Maegawa S, Nakata M, Hagiwara M (2020): Different effects of methylphenidate and atomoxetine on the behavior and brain transcriptome of zebrafish. Mol Brain. 2020 May 6;13(1):70. doi: 10.1186/s13041-020-00614-4. PMID: 32375837; PMCID: PMC7203832.

  4. Krieg S, Konrad M, Krieg A, Kostev K (2024): What Is the Link between Attention-Deficit/Hyperactivity Disorder (ADHD) and Dyslipidemia in Adults? A German Retrospective Cohort Study. J Clin Med. 2024 Jul 30;13(15):4460. doi: 10.3390/jcm13154460. PMID: 39124726; PMCID: PMC11312942.

  5. Irmisch, Richter, Thome, Sheldrick, Wandschneider (2013): Altered serum mono- and polyunsaturated fatty acid levels in adults with ADHD. Atten Defic Hyperact Disord. 2013 Sep;5(3):303-11. doi: 10.1007/s12402-013-0107-9. n = 30

  6. Young GS, Maharaj NJ, Conquer JA (2004): Blood phospholipid fatty acid analysis of adults with and without attention deficit/hyperactivity disorder. Lipids. 2004 Feb;39(2):117-23. doi: 10.1007/s11745-004-1209-3. PMID: 15134138.

  7. Burgess JR, Stevens L, Zhang W, Peck L (2000): Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder. Am J Clin Nutr. 2000 Jan;71(1 Suppl):327S-30S. doi: 10.1093/ajcn/71.1.327S. PMID: 10617991. REVIEW

  8. D’Helft, Caccialanza, Derbyshire, Maes (2022): Relevance of ω-6 GLA Added to ω-3 PUFAs Supplements for ADHD: A Narrative Review. Nutrients. 2022 Aug 10;14(16):3273. doi: 10.3390/nu14163273. PMID: 36014778.

  9. Shin BC, Ghosh S, Dai Y, Byun SY, Calkins KL, Devaskar SU (2019): Early life high-fat diet exposure maintains glucose tolerance and insulin sensitivity with a fatty liver and small brain size in the adult offspring. Nutr Res. 2019 Sep;69:67-81. doi: 10.1016/j.nutres.2019.08.004. PMID: 31639589; PMCID: PMC6934265.

  10. Ozerskaia IV, Khachatryan LG, Kolosova NG, Polyanskaya AV, Kasanave EV (2024): [The role of ω-3 polyunsaturated fatty acids in child development]. Vopr Pitan. 2024;93(2):6-18. Russian. doi: 10.33029/0042-8833-2024-93-2-6-18. Epub 2024 Feb 1. PMID: 38809795. REVIEW

  11. Pérez, Peñaloza-Sancho, Ahumada, Fuenzalida, Dagnino-Subiabre (2018): n-3 Polyunsaturated fatty acid supplementation restored impaired memory and GABAergic synaptic efficacy in the hippocampus of stressed rats. Nutr Neurosci. 2018 Oct;21(8):556-569. doi: 10.1080/1028415X.2017.1323609.

  12. IMD Labor Berlin: Fettsäurestatus der Erythrozytenmembran german, visited 05/2025

  13. Hawkey E, Nigg JT (2014): Omega-3 fatty acid and ADHD: blood level analysis and meta-analytic extension of supplementation trials. Clin Psychol Rev. 2014 Aug;34(6):496-505. doi: 10.1016/j.cpr.2014.05.005. PMID: 25181335; PMCID: PMC4321799. METASTUDY

  14. Antalis CJ, Stevens LJ, Campbell M, Pazdro R, Ericson K, Burgess JR (2006): Omega-3 fatty acid status in attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids. 2006 Oct-Nov;75(4-5):299-308. doi: 10.1016/j.plefa.2006.07.004. PMID: 16962757.

  15. Colter AL, Cutler C, Meckling KA (2008): Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study. Nutr J. 2008 Feb 14;7:8. doi: 10.1186/1475-2891-7-8. PMID: 18275609; PMCID: PMC2275745. n = 23

  16. Parletta N, Niyonsenga T, Duff J (2016): Omega-3 and Omega-6 Polyunsaturated Fatty Acid Levels and Correlations with Symptoms in Children with Attention Deficit Hyperactivity Disorder, Autistic Spectrum Disorder and Typically Developing Controls. PLoS One. 2016 May 27;11(5):e0156432. doi: 10.1371/journal.pone.0156432. PMID: 27232999; PMCID: PMC4883772. n = 480

  17. Laasonen M, Hokkanen L, Leppämäki S, Tani P, Erkkilä AT (2009): Project DyAdd: Fatty acids in adult dyslexia, ADHD, and their comorbid combination. Prostaglandins Leukot Essent Fatty Acids. 2009 Jul;81(1):89-96. doi: 10.1016/j.plefa.2009.04.005. PMID: 19523794. n = 107

  18. Spahis S, Vanasse M, Bélanger SA, Ghadirian P, Grenier E, Levy E (2008): Lipid profile, fatty acid composition and pro- and anti-oxidant status in pediatric patients with attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids. 2008 Jul-Aug;79(1-2):47-53. doi: 10.1016/j.plefa.2008.07.005. PMID: 18757191. n = 72

  19. Yonezawa, Nonaka, Iwakura, Kusano, Funamoto, Kanchi, Yamaguchi, Kusumoto, Imamura, Ozawa (2018): Investigation into the plasma concentration of ω3 polyunsaturated fatty acids in Japanese attention-deficit hyperactivity disorder patients. J Neural Transm (Vienna). 2018 Jun 20. doi: 10.1007/s00702-018-1895-z.; n = 24

  20. Chen JR, Hsu SF, Hsu CD, Hwang LH, Yang SC (2004): Dietary patterns and blood fatty acid composition in children with attention-deficit hyperactivity disorder in Taiwan. J Nutr Biochem. 2004 Aug;15(8):467-72. doi: 10.1016/j.jnutbio.2004.01.008. PMID: 15302081. n = 24

  21. Abdullah M, Jowett B, Whittaker PJ, Patterson L (2019): The effectiveness of omega-3 supplementation in reducing ADHD associated symptoms in children as measured by the Conners’ rating scales: A systematic review of randomized controlled trials. J Psychiatr Res. 2019 Mar;110:64-73. doi: 10.1016/j.jpsychires.2018.12.002. PMID: 30594823.

  22. Hariri, Djazayery, Djalali, Saedisomeolia, Rahimi, Abdolahian (2012): Effect of n-3 supplementation on hyperactivity, oxidative stress and inflammatory mediators in children with attention-deficit-hyperactivity disorder. Malays J Nutr. 2012 Dec;18(3):329-35. n = 103

  23. Bos, Oranje, Veerhoek, Van Diepen, Weusten, Demmelmair, Koletzko, de Sain-van der Velden, Eilander, Hoeksma, Durston (2015): Reduced Symptoms of Inattention after Dietary Omega-3 Fatty Acid Supplementation in Boys with and without Attention Deficit/Hyperactivity Disorder. Neuropsychopharmacology. 2015 Sep;40(10):2298-306. doi: 10.1038/npp.2015.73. PMID: 25790022; PMCID: PMC4538345. n = 79

  24. Pinar-Martí A, Gignac F, Fernández-Barrés S, Romaguera D, Sala-Vila A, Lázaro I, Ranzani OT, Persavento C, Delgado A, Carol A, Torrent J, Gonzalez J, Roso E, Barrera-Gómez J, López-Vicente M, Boucher O, Nieuwenhuijsen M, Turner MC, Burgaleta M, Canals J, Arija V, Basagaña X, Ros E, Salas-Salvadó J, Sunyer J, Julvez J (2023): Effect of walnut consumption on neuropsychological development in healthy adolescents: a multi-school randomised controlled trial. EClinicalMedicine. 2023 Apr 6;59:101954. doi: 10.1016/j.eclinm.2023.101954. PMID: 37096186; PMCID: PMC10121389. RCT

  25. Carucci, Romaniello, Demuru, Curatolo, Grelloni, Masi, Liboni, Mereu, Contu, Lamberti, Gagliano, Zuddas (2022): Omega-3/6 supplementation for mild to moderate inattentive ADHD: a randomised, double-blind, placebo-controlled efficacy study in Italian children. Eur Arch Psychiatry Clin Neurosci. 2022 Jun 7. doi: 10.1007/s00406-022-01428-2. PMID: 35672606. RCT, n = 160

  26. Wang Z, Zhu H, Chen L, Gan C, Min W, Xiao J, Zou Z, He Y (2024): Absence of Causal Relationship Between Levels of Unsaturated Fatty Acids and ADHD: Evidence From Mendelian Randomization Study. J Atten Disord. 2024 Dec;28(14):1716-1725. doi: 10.1177/10870547241264660. PMID: 39082434.

  27. Wang, Yu, Fu, Yeh, Hsu, Yang, Yang, Huang, Wei, Chen, Chiang, Pan (2019): Dietary Profiles, Nutritional Biochemistry Status, and Attention-Deficit/Hyperactivity Disorder: Path Analysis for a Case-Control Study. J Clin Med. 2019 May 18;8(5). pii: E709. doi: 10.3390/jcm8050709. n = 432

  28. Ugur, Uneri, Goker, Sekmen, Aydemir, Solmaz (2018): The assessment of serum lipid profiles of children with attention deficit hyperactivity disorder. .Psychiatry Res. 2018 Apr 7;264:231-235. doi: 10.1016/j.psychres.2018.04.006. n = 176

  29. Avcil (2018): Association between altered lipid profiles and attention deficit hyperactivity disorder in boys, Nordic Journal of Psychiatry, 72:5, 361-366, DOI: 10.1080/08039488.2018.1465591

  30. Pinho, Wang, Becker, Rothenberger, Outeiro, Herrmann-Lingen, Meyer (2018): Attention-deficit/hyperactivity disorder is associated with reduced levels of serum low-density lipoprotein cholesterol in adolescents. Data from the population-based German KiGGS study., World J Biol Psychiatry. 2018 Jan 11:1-9. doi: 10.1080/15622975.2017.1417636. n = 6.898

  31. Huber F, Schulz J, Schlack R, Hölling H, Ravens-Sieberer U, Meyer T, Rothenberger A, Wang B, Becker A (2023): Long-term changes in serum levels of lipoproteins in children and adolescents with attention-deficit/hyperactivity disorder (ADHD). J Neural Transm (Vienna). 2023 Feb 24. doi: 10.1007/s00702-022-02583-5. PMID: 36826608.

  32. McIntyre, Alsuwaidan, Soczynska, Szpindel, Bilkey, Almagor, Woldeyohannes, Powell, Cha, Gallaugher, Kennedy (2013): The effect of lisdexamfetamine dimesylate on body weight, metabolic parameters, and attention deficit hyperactivity disorder symptomatology in adults with bipolar I/II disorder. Hum Psychopharmacol. 2013 Sep;28(5):421-7. doi: 10.1002/hup.2325. n = 45

  33. Yamamoto, Okuzaki, Yamanishi, Xu, Watanabe, Yoshid, Yamashita, Goto, Nishiguchi, Shimada, Nojima, Yasunaga, Okamura, Matsunaga, Yamanishi (2013): Genetic analysis of genes causing hypertension and stroke in spontaneously hypertensive rats. Int J Mol Med. 2013 May;31(5):1057-65. doi: 10.3892/ijmm.2013.1304.

  34. Irmisch, Thom, Reis, Hässler, Weirich (2011): Modified magnesium and lipoproteins in children with attention deficit hyperactivity disorder (ADHD). World J Biol Psychiatry. 2011 Sep;12 Suppl 1:63-5. doi: 10.3109/15622975.2011.600292. n = 20

  35. Charach, Kaysar, Grosskopf, Rabinovich, Weintraub (2009): Methylphenidate has positive hypocholesterolemic and hypotriglyceridemic effects: new data. J Clin Pharmacol. 2009 Jul;49(7):848-51. doi: 10.1177/0091270009336736. n = 42

  36. Irmisch, Richter, Thome, Sheldrick, Wandschneider (2013): Altered serum mono- and polyunsaturated fatty acid levels in adults with ADHD. Atten Defic Hyperact Disord. 2013 Sep;5(3):303-11. doi: 10.1007/s12402-013-0107-9.

  37. Pärtty A, Kalliomäki M, Wacklin P, Salminen S, Isolauri E (2015): A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial. Pediatr Res. 2015 Jun;77(6):823-8. doi: 10.1038/pr.2015.51. PMID: 25760553., n = 75

  38. Kumperscak HG, Gricar A, Ülen I, Micetic-Turk D (2020): A Pilot Randomized Control Trial With the Probiotic Strain Lactobacillus rhamnosus GG (LGG) in ADHD: Children and Adolescents Report Better Health-Related Quality of Life. Front Psychiatry. 2020 Mar 17;11:181. doi: 10.3389/fpsyt.2020.00181. PMID: 32256407; PMCID: PMC7092625. RCT, n = 35

  39. Wang LJ, Yang CY, Kuo HC, Chou WJ, Tsai CS, Lee SY (2022): Effect of Bifidobacterium bifidum on Clinical Characteristics and Gut Microbiota in Attention-Deficit/Hyperactivity Disorder. J Pers Med. 2022 Feb 7;12(2):227. doi: 10.3390/jpm12020227. PMID: 35207715; PMCID: PMC8877879. n = 30

  40. Wang LJ, Tsai CS, Chou WJ, Kuo HC, Huang YH, Lee SY, Dai HY, Yang CY, Li CJ, Yeh YT (2024): Add-On Bifidobacterium Bifidum Supplement in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Week Randomized Double-Blind Placebo-Controlled Clinical Trial. Nutrients. 2024 Jul 13;16(14):2260. doi: 10.3390/nu16142260. PMID: 39064703; PMCID: PMC11279422. n = 102

  41. Ghanaatgar M, Taherzadeh S, Ariyanfar S, Razeghi Jahromi S, Martami F, Mahmoudi Gharaei J, Teimourpour A,Shahrivar Z (2023): Probiotic supplement as an adjunctive therapy with Ritalin for treatment of attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled randomized clinical trial“, Nutrition & Food Science, Vol. 53 No. 1, pp. 19-34. doi.org/10.1108/NFS-12-2021-0388, RCT, n = 38

  42. Sepehrmanesh Z, Shahzeidi A, Mansournia M, Ghaderi A, Ahmadvand A (2021): Clinical and Metabolic Reaction to Probiotic Supplement in Children Suffering Attention-Deficit Hyperactivity Disorder. A Randomized, Double-Blind, Placebo-Controlled Experiment. International Archives of Health Sciences 8(2):p 90-96, Apr–Jun 2021. | DOI: 10.4103/iahs.iahs_112_20. RCT, n = 34

  43. Skott E, Yang LL, Stiernborg M, Söderström Å, Rȕegg J, Schalling M, Forsell Y, Giacobini M, Lavebratt C. Effects of a synbiotic on symptoms, and daily functioning in attention deficit hyperactivity disorder - A double-blind randomized controlled trial. Brain Behav Immun. 2020 Oct;89:9-19. doi: 10.1016/j.bbi.2020.05.056. PMID: 32497779., RCT, n = 182

  44. Sangsefidi ZS, Sangsefidi ZS, Moharreri F, Heydari Yazdi AS, Eslami S, Emadzadeh B, Ghorani B, Sarabi-Jamab M, Farahmand A, Modiri Dovom A, Ghanaei A, Emadzadeh M (2024): Effect of probiotics as an adjunctive therapy with Ritalin among ADHD children and adolescents: a triple-blind randomized controlled trial. Nutr Neurosci. 2024 Aug 20:1-10. doi: 10.1080/1028415X.2024.2391655. PMID: 39163291. n = 60

  45. Levy Schwartz M, Magzal F, Yehuda I, Tamir S (2024): Exploring the impact of probiotics on adult ADHD management through a double-blind RCT. Sci Rep. 2024 Nov 5;14(1):26830. doi: 10.1038/s41598-024-73874-y. PMID: 39500949; PMCID: PMC11538393.

  46. Liang SC, Sun CK, Chang CH, Cheng YS, Tzang RF, Chiu HJ, Wang MY, Cheng YC, Hung KC (2024): Therapeutic efficacy of probiotics for symptoms of attention-deficit hyperactivity disorder in children and adolescents: meta-analysis. BJPsych Open. 2024 Jan 25;10(1):e36. doi: 10.1192/bjo.2023.645. PMID: 38268113.

  47. Tengeler, Dam, Wiesmann, Naaijen, van Bodegom, Belzer, Dederen, Verweij, Franke, Kozicz, Arias Vasquez, Kiliaan (2020): Gut microbiota from persons with attention-deficit/hyperactivity disorder affects the brain in mice. Microbiome. 2020 Apr 1;8(1):44. doi: 10.1186/s40168-020-00816-x. PMID: 32238191; PMCID: PMC7114819.

  48. Hooi, Dwiyanto, Rasiti, Toh, Wong RKM, Lee JWJ (2022): A case report of improvement on ADHD symptoms after fecal microbiota transplantation with gut microbiome profiling pre- and post-procedure. Curr Med Res Opin. 2022 Sep 26:1-13. doi: 10.1080/03007995.2022.2129232. PMID: 36164761.

  49. Citraro, Navarra, Leo, Donato Di Paola, Santangelo, Lippiello, Aiello, Russo, De Sarro (2016): The Anticonvulsant Activity of a Flavonoid-Rich Extract from Orange Juice Involves both NMDA and GABA-Benzodiazepine Receptor Complexes. Molecules. 2016 Sep 21;21(9). pii: E1261.

  50. Donoso, Egerton, Bastiaanssen, Fitzgerald, Gite, Fouhy, Ross, Stanton, Dinan, Cryan (2020): Polyphenols selectively reverse early-life stress-induced behavioural, neurochemical and microbiota changes in the rat. Psychoneuroendocrinology. 2020 Jun;116:104673. doi: 10.1016/j.psyneuen.2020.104673. PMID: 32334345.

  51. Darzi M, Abbasi K, Ghiasvand R, Akhavan Tabib M, Rouhani MH (2022): The association between dietary polyphenol intake and attention-deficit hyperactivity disorder: a case-control study. BMC Pediatr. 2022 Dec 6;22(1):700. doi: 10.1186/s12887-022-03768-3. PMID: 36474220; PMCID: PMC9724259. n = 400

  52. Bieger (2006): Neuroscience Guide – Ein innovatives, diagnostisches und therapeutisches Stufenprogramm bei Neurotransmitter-Störungen, Seite 19

Diese Seite wurde am 25.05.2025 zuletzt aktualisiert.